Literature DB >> 27891373

Retrospective Comparison of Clinical Characteristics and In-Hospital Outcomes among Diabetic and Non-Diabetic Adults with Acute Pyelonephritis.

Shailesh C Trivedi1, Sanjeev R Phatak2, Renu S Trivedi3.   

Abstract

INTRODUCTION: Acute Pyelonephritis (APN) is a common infection in community. Diabetes Mellitus (DM) may have different effect on clinical characteristics and outcomes of APN compared to non-diabetic individuals. AIM: To compare clinical characteristics and assess outcomes of APN patients with and without DM.
MATERIALS AND METHODS: A retrospective analysis of 122 patients with DM (n=61) and without DM (n=61) was conducted at a single, private, urban set-up from Gujarat, India. Clinical symptoms, laboratory investigations, antibiotics treatment and outcomes in terms of mortality and prolonged hospitalization (10 days and above) were compared in two groups.
RESULTS: Mean age was significantly higher in diabetics than non-diabetics (55.2±12.5 vs 41.5±17.3, p<0.0001) and females were proportionally higher in both groups (65.6% Vs 62.3%, p=0.706). Fever was most frequent symptom (83.6% Vs 90.2%, p=0.283) followed by nausea/vomiting (50.8% Vs 63.9%, p=0.143), dysuria (66.7% Vs 74.4%, p=0.433) and flank pain (8.2 Vs 13.1, p=0.379). Backache/back pain (47.5% Vs 29.5%, p=0.041) and Chronic Kidney Disease (CKD) (63.9% Vs 45.9%, p=0.045) were significantly higher in diabetics than non-diabetics. Mean hospital stay did not vary significantly in two groups (7.0±3.2 Vs 6.50±2.9, p=0.346) but proportion of patients with longer hospital stay was higher in DM (16.4% Vs 8.2%). Elevated white cell count, erythrocyte sedimentation rate, C-reactive protein, serum creatinine and presence of red cell in urine (> 5/ high power field [hpf]) did not vary significantly in two groups. Cephalosporin-beta-lactamase inhibitor (Cefaperazone-Sulbactam/Cefepime-Tazobactam) was the most prescribed antibiotic in both the groups. No deaths were observed in any group during this evaluation period. Only raised ESR (>30 mm/hr) {Odds Ratio (OR): 1.58, 95% Confidence Interval (CI) 1.36-1.82, p=0.004} and presence of CKD (OR: 1.71, 95% CI 1.30-2.25, p=0.008) were found to be the significant predictors of prolonged hospitalization in overall population.
CONCLUSION: APN in diabetic and non-diabetic patients has similar clinical characteristics. Impact of diabetes on clinical outcomes of mortality and prolonged hospitalization warrants further investigation in a large, randomized, prospective trial.

Entities:  

Keywords:  Chronic kidney disease; Prolonged hospitalization; Risk predictors

Year:  2016        PMID: 27891373      PMCID: PMC5121711          DOI: 10.7860/JCDR/2016/22830.8720

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

1.  Evaluation of the efficacy and tolerance of a short 7 day third-generation cephalosporin treatment in the management of acute pyelonephritis in young women in the emergency department.

Authors:  F Moustafa; G Nguyen; T Mathevon; O Baud; J Saint-Denis; N Dublanchet; B Pereira; C Shinjo; J P Romaszko; L Dopeux; F Dutheil; J Schmidt
Journal:  J Antimicrob Chemother       Date:  2016-02-21       Impact factor: 5.790

Review 2.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

3.  Risk factors for a poor outcome after therapy for acute pyelonephritis.

Authors:  Peter E Pertel; Daniel Haverstock
Journal:  BJU Int       Date:  2006-07       Impact factor: 5.588

4.  The epidemiology of acute pyelonephritis in South Korea, 1997-1999.

Authors:  Moran Ki; Taesung Park; Boyoul Choi; Betsy Foxman
Journal:  Am J Epidemiol       Date:  2004-11-15       Impact factor: 4.897

5.  Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis.

Authors:  Diamantis P Kofteridis; Eva Papadimitraki; Elpis Mantadakis; Sofia Maraki; John A Papadakis; Garifallia Tzifa; George Samonis
Journal:  J Am Geriatr Soc       Date:  2009-11       Impact factor: 5.562

6.  Population-based epidemiologic analysis of acute pyelonephritis.

Authors:  Christopher A Czaja; Delia Scholes; Thomas M Hooton; Walter E Stamm
Journal:  Clin Infect Dis       Date:  2007-06-19       Impact factor: 9.079

7.  Acute pyelonephritis in adults: prediction of mortality and failure of treatment.

Authors:  Stamatis P Efstathiou; Angelos V Pefanis; Dimitrios I Tsioulos; Ioannis D Zacharos; Aphrodite G Tsiakou; Athanasios G Mitromaras; Stylianos E Mastorantonakis; Sophie N Kanavaki; Theodore D Mountokalakis
Journal:  Arch Intern Med       Date:  2003-05-26

8.  Severe acute pyelonephritis: a review of clinical outcome and risk factors for mortality.

Authors:  Vera Y Chung; C K Tai; C W Fan; C N Tang
Journal:  Hong Kong Med J       Date:  2014-03-14       Impact factor: 2.227

9.  Acute pyelonephritis in diabetes mellitus: Single center experience.

Authors:  S Kumar; R Ramachandran; U Mete; T Mittal; P Dutta; V Kumar; M Rathi; V Jha; K L Gupta; V Sakhuja; H S Kohli
Journal:  Indian J Nephrol       Date:  2014-11

10.  New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records.

Authors:  H I McDonald; D Nitsch; E R C Millett; A Sinclair; S L Thomas
Journal:  Diabet Med       Date:  2014-02-12       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.